Goldman Sachs
SLGC

Goldman Sachs’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Goldman Sachs’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,020,601
Closed -$2.58M – 6019
2023
Q4 		$2.58M Sell
1,020,601
-56,640
-5% -$132K ﹤0.01% 3725
2023
Q3 		$2.57M Buy
1,077,241
+231,982
+27% +$514K ﹤0.01% 3563
2023
Q2 		$1.95M Buy
845,259
+139,619
+20% +$394K ﹤0.01% 3894
2023
Q1 		$1.8M Sell
705,640
-3,654
-0.5% -$10.5K ﹤0.01% 3948
2022
Q4 		$1.78M Sell
709,294
-194,755
-22% -$543K ﹤0.01% 4029
2022
Q3 		$2.62M Buy
904,049
+219,957
+32% +$926K ﹤0.01% 3732
2022
Q2 		$3.09M Sell
684,092
-1,436,680
-68% -$8.55M ﹤0.01% 3642
2022
Q1 		$17M Buy
2,120,772
+2,050,401
+2,914% +$18.1M ﹤0.01% 2185
2021
Q4 		$819K Buy
+70,371
New +$843K ﹤0.01% 5017

Goldman Sachs's SLGC Position: Q1 2024 in Review

Goldman Sachs sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 1,020,601 shares — an estimated $2.58M sold.

Goldman Sachs first reported a position in SLGC in Q4 2021 and held it in 9 quarters. The position peaked at $17M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Goldman Sachs reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Goldman Sachs sold 1,020,601 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $2.58M.
  • Goldman Sachs first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 9 quarters.
  • Goldman Sachs's SomaLogic, Inc. Class A Common Stock position peaked at $17M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.